2023 annual financial data

Protara Therapeutics 2023 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -43.61M USD and net income was -40.42M USD.
Operating cash flow was -37.56M USD.

Get free Protara Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-43.61M USD
Net income
-40.42M USD
Operating cash flow
-37.56M USD